Targeted therapies Defining the best-in-class in NSCLC

被引：5

|

作者：

Hutchinson, Lisa

机构：

来源：

NATURE REVIEWS CLINICAL ONCOLOGY | 2017年 / 14卷 / 08期

关键词：

D O I：

10.1038/nrclinonc.2017.99

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：457 / 457

页数：1

相关论文

共 50 条

[21] What matters most in commercial success: first-in-class or best-in-class?
Schulze, Ulrik
Ringel, Michael
NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (06) : 419 - 420
[22] ADVANCED NSCLC: MAINTENANCE WITH TARGETED THERAPIES
Gridelli, C.
LUNG CANCER, 2011, 71 : S24 - S24
[23] Targeted Therapies in NSCLC - present and future
Pall, Georg
Hilbe, Wolfgang
WIENER MEDIZINISCHE WOCHENSCHRIFT, 2007, 157 (21-22) : 545 - 553
[24] POWER MANAGEMENT ICS OPTIMISE BEST-IN-CLASS CIRCUIT BLOCKS
Knoth, Steve
ELECTRONICS WORLD, 2008, 114 (1872): : 24 - 27
[25] Towards realizing best-in-class civil aviation strategy scenarios
Itani, Nadine
O'Connell, John F.
Mason, Keith
TRANSPORT POLICY, 2015, 43 : 42 - 54
[26] First-in-class versus best-in-class: an update for new market dynamics
Lindsay Spring
Kunle Demuren
Michael Ringel
John Wu
Nature Reviews Drug Discovery, 2023, 22 : 531 - 532
[27] Crowdsourced contest identifies best-in-class breast cancer prognostic
Eisenstein, Michael
NATURE BIOTECHNOLOGY, 2013, 31 (07) : 578 - 580
[28] Crowdsourced contest identifies best-in-class breast cancer prognostic
Michael Eisenstein
Nature Biotechnology, 2013, 31 : 578 - 579
[29] Magnolia deepwater development - Striving for best-in-class drilling performance
Reinhardt, W. Randall
Williamson, Roger N.
Eaton, Luke F.
Actis, Stephen C.
SPE DRILLING & COMPLETION, 2006, 21 (04) : 268 - 278
[30] Survey highlights why best-in-class companies lead the pack
不详
QUALITY PROGRESS, 1996, 29 (08) : 14 - &

← 1 2 3 4 5 →